Small molecules that interfere with mortalin-p53 interaction, including MKT-077, Withaferin A and CAPE and specific anti-mortalin molecules (ribosomes, shRNA) were shown to activate p53 and resulting in growth arrest of cancer cells [12, 48–52]. Here, HSPA9 is linked to cancer.